Home › NDC Lookup › RxCUI directory › RxCUI 602223

Dimenhydrinate 50 MG Chewable Tablet [Dramamine] — RxCUI 602223

RxNorm drug concept · Semantic branded drug
RxCUI 602223 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI602223
Official nameDimenhydrinate 50 MG Chewable Tablet [Dramamine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDramamine 50 MG Chewable Tablet
FDA products mapped4
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dimenhydrinate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It prevents and treats the nausea, vomiting and dizziness of motion sickness. You'll see it in products like Dramamine and Gravol, and as an injection used in medical settings.
  • To prevent motion sickness, take your first dose about 30 to 60 minutes before you start traveling. After that, follow the repeat timing and daily limit on your product's label. Ch...
  • Quite possibly. Drowsiness is the most common side effect. Be careful driving or using machinery, and skip alcohol.
  • Tell me what else you take. Sedatives, tranquilizers and other sedating drugs can add to drowsiness. It can also hide warning signs of ear damage from certain antibiotics.
📖 Read our full Dimenhydrinate guide →

🕸️ Concept Web — How Dimenhydrinate 50 MG Chewable Tablet [Dramamine] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dimenhydrinate 50 MG Chewable Tablet [Dramamine] RxCUI 602223

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dimenhydrinate 3444
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dramamine 151666
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dimenhydrinate Chewable Tablet 371861
    • Dimenhydrinate Chewable Product 1294911
    • Dimenhydrinate Oral Product 1151896
    • Dimenhydrinate Pill 1151897
    • Dimenhydrinate Chewable Tablet [Dramamine] 602222
    • Dramamine Chewable Product 1296525
    • Dramamine Oral Product 1175934
    • Dramamine Pill 1175935
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dimenhydrinate 50 MG Chewable Tablet SCD · 309913
  • Dimenhydrinate 50 MG SCDC · 315830
  • Dimenhydrinate Chewable Tablet SCDF · 371861
  • Dimenhydrinate Chewable Product SCDG · 1294911
  • Dimenhydrinate Oral Product SCDG · 1151896
  • Dimenhydrinate Pill SCDG · 1151897

Brand-Name Concepts

  • Dimenhydrinate 50 MG [Dramamine] SBDC · 565985
  • Dimenhydrinate Chewable Tablet [Dramamine] SBDF · 602222
  • Dramamine Chewable Product SBDG · 1296525
  • Dramamine Oral Product SBDG · 1175934
  • Dramamine Pill SBDG · 1175935
  • Dramamine BN · 151666

📦 FDA Products & Package NDCs

4 products · 7 package NDCs
7 package NDCs map to RxCUI 602223 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50269-0525-00 2 PACKET in 1 BOX (50269-525-00) / 20 TABLET, CHEWABLE in 1... Dramamine Chewable Dimenhydrinate JC World Bell Wholesale Co., Inc. 2012-01-15
63029-0902-01 1 BLISTER PACK in 1 BOX (63029-902-01) / 8 TABLET, CHEWABLE... Dramamine Orange Medtech Products Inc. 2012-01-15
63029-0902-02 2 TABLET, CHEWABLE in 1 POUCH (63029-902-02) Dramamine Orange Medtech Products Inc. 2012-01-15
66715-6409-02 1 POUCH in 1 CARTON (66715-6409-2) / 2 TABLET, CHEWABLE in... Dramamine, TRAVEL BASIX Lil' Drug Store Products, Inc. 2022-11-28
66715-9809-01 1 POUCH in 1 CARTON (66715-9809-1) / 2 TABLET, CHEWABLE in... Dramamine Lil' Drug Store Products, Inc. 2016-08-26
66715-9809-02 2 POUCH in 1 CARTON (66715-9809-2) / 2 TABLET, CHEWABLE in... Dramamine Lil' Drug Store Products, Inc. 2022-05-16
66715-9809-07 25 POUCH in 1 BOX, UNIT-DOSE (66715-9809-7) / 2 TABLET, CHE... Dramamine Lil' Drug Store Products, Inc. 2022-04-19
Observed labelers: Lil' Drug Store Products, Inc. (4) · Medtech Products Inc. (2) · JC World Bell Wholesale Co., Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.